VP22 does not significantly enhance enzyme prodrug cancer...

The Journal of Gene Medicine 2005 Vol. 7; Iss. 7

VP22 does not significantly enhance enzyme prodrug cancer gene therapy as a part of a VP22-HSVTk-GFP triple fusion construct

Tanja Hakkarainen, Tiina Wahlfors, Outi Meriläinen, Sami Loimas, Akseli Hemminki, Jarmo Wahlfors
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
7
Year:
2005
Language:
english
Pages:
10
DOI:
10.1002/jgm.737
File:
PDF, 270 KB
english, 2005
Conversion to is in progress
Conversion to is failed